SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Thompson JR) "

Sökning: WFRF:(Thompson JR)

  • Resultat 141-150 av 151
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
141.
  •  
142.
  • Wang, Anqi, et al. (författare)
  • Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants
  • 2023
  • Ingår i: Nature Genetics. - : Springer Nature. - 1061-4036 .- 1546-1718. ; 55:12, s. 2065-2074
  • Tidskriftsartikel (refereegranskat)abstract
    • The transferability and clinical value of genetic risk scores (GRSs) across populations remain limited due to an imbalance in genetic studies across ancestrally diverse populations. Here we conducted a multi-ancestry genome-wide association study of 156,319 prostate cancer cases and 788,443 controls of European, African, Asian and Hispanic men, reflecting a 57% increase in the number of non-European cases over previous prostate cancer genome-wide association studies. We identified 187 novel risk variants for prostate cancer, increasing the total number of risk variants to 451. An externally replicated multi-ancestry GRS was associated with risk that ranged from 1.8 (per standard deviation) in African ancestry men to 2.2 in European ancestry men. The GRS was associated with a greater risk of aggressive versus non-aggressive disease in men of African ancestry (P = 0.03). Our study presents novel prostate cancer susceptibility loci and a GRS with effective risk stratification across ancestry groups.
  •  
143.
  • Webb, JG, et al. (författare)
  • Percutaneous transvenous mitral annuloplasty - Initial human experience with device implantation in the coronary sinus
  • 2006
  • Ingår i: Circulation. - 1524-4539. ; 113:6, s. 851-855
  • Tidskriftsartikel (refereegranskat)abstract
    • Background - Mitral annuloplasty is the most common surgical procedure performed for ischemic mitral regurgitation (MR). Surgical mitral annuloplasty is limited by morbidity, mortality, and MR recurrence. We evaluated the safety and feasibility of a transvenous catheter-delivered implantable device to provide a percutaneous alternative to surgical mitral annuloplasty. Methods and Results - Five patients with chronic ischemic MR underwent percutaneous transvenous implantation of an annuloplasty device in the coronary sinus. Implantation was successful in 4 patients. Baseline MR in the entire group was grade 3.0 +/- 0.7 and was reduced to grade 1.6 +/- 1.1 at the last postimplantation visit when the device was intact or the last postprocedural visit in the patient in whom the device was not successfully implanted. Separation of the bridge section of the device occurred in 3 of 4 implanted devices and was detected at 28 to 81 days after implantation. There were no postprocedural device-related complications. Conclusions - Percutaneous implantation of a device intended to remodel the mitral annulus is feasible. Initial experience suggests a possible favorable effect on MR. Percutaneous transvenous mitral annuloplasty warrants further evaluation as a less invasive alternative to surgical annuloplasty.
  •  
144.
  • Wedemeyer, H., et al. (författare)
  • Strategies to manage hepatitis C virus (HCV) disease burden
  • 2014
  • Ingår i: Journal of Viral Hepatitis. - Hoboken : Wiley-Blackwell. - 1352-0504 .- 1365-2893. ; 21, s. 60-89
  • Tidskriftsartikel (refereegranskat)abstract
    • The number of hepatitis C virus (HCV) infections is projected to decline while those with advanced liver disease will increase. A modeling approach was used to forecast two treatment scenarios: (i) the impact of increased treatment efficacy while keeping the number of treated patients constant and (ii) increasing efficacy and treatment rate. This analysis suggests that successful diagnosis and treatment of a small proportion of patients can contribute significantly to the reduction of disease burden in the countries studied. The largest reduction in HCV-related morbidity and mortality occurs when increased treatment is combined with higher efficacy therapies, generally in combination with increased diagnosis. With a treatment rate of approximately 10%, this analysis suggests it is possible to achieve elimination of HCV (defined as a >90% decline in total infections by 2030). However, for most countries presented, this will require a 3-5 fold increase in diagnosis and/or treatment. Thus, building the public health and clinical provider capacity for improved diagnosis and treatment will be critical.
  •  
145.
  •  
146.
  •  
147.
  •  
148.
  • Yun, JY, et al. (författare)
  • Corrigendum
  • 2020
  • Ingår i: Brain : a journal of neurology. - : Oxford University Press (OUP). - 1460-2156. ; 143:5, s. e44-
  • Tidskriftsartikel (refereegranskat)
  •  
149.
  •  
150.
  • Zhou, XP, et al. (författare)
  • Non-coding variability at the APOE locus contributes to the Alzheimer's risk
  • 2019
  • Ingår i: Nature communications. - : Springer Science and Business Media LLC. - 2041-1723. ; 10:1, s. 3310-
  • Tidskriftsartikel (refereegranskat)abstract
    • Alzheimer’s disease (AD) is a leading cause of mortality in the elderly. While the coding change of APOE-ε4 is a key risk factor for late-onset AD and has been believed to be the only risk factor in the APOE locus, it does not fully explain the risk effect conferred by the locus. Here, we report the identification of AD causal variants in PVRL2 and APOC1 regions in proximity to APOE and define common risk haplotypes independent of APOE-ε4 coding change. These risk haplotypes are associated with changes of AD-related endophenotypes including cognitive performance, and altered expression of APOE and its nearby genes in the human brain and blood. High-throughput genome-wide chromosome conformation capture analysis further supports the roles of these risk haplotypes in modulating chromatin states and gene expression in the brain. Our findings provide compelling evidence for additional risk factors in the APOE locus that contribute to AD pathogenesis.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 141-150 av 151
Typ av publikation
tidskriftsartikel (136)
forskningsöversikt (5)
konferensbidrag (2)
Typ av innehåll
refereegranskat (131)
övrigt vetenskapligt/konstnärligt (13)
Författare/redaktör
Montgomery, GW (30)
Martin, NG (29)
Medland, SE (27)
Hottenga, JJ (26)
Esko, T (26)
Breen, G (25)
visa fler...
Metspalu, A (25)
Cichon, S (24)
Smoller, JW (24)
Stefansson, K (24)
Teumer, A (23)
Nothen, MM (23)
Mattheisen, M (22)
Rietschel, M (22)
Ripke, S (22)
Willemsen, G (21)
Boomsma, DI (21)
McIntosh, AM (21)
Yang, J. (20)
Stein, DJ (19)
Craddock, N (19)
Werge, T (19)
Hoffmann, P (19)
Homuth, G (19)
Muller-Myhsok, B (19)
O'Donovan, MC (19)
Gill, M. (19)
Hayward, C. (19)
Wang, Z. (18)
Giles, GG (18)
Uitterlinden, AG (18)
Lucae, S (18)
Schulze, TG (18)
Southey, MC (18)
Herms, S. (18)
Strohmaier, J (18)
Frank, J (18)
Wu, Y. (17)
Zheng, W. (17)
Wang, YP (17)
Sullivan, PF (17)
Thompson, PM (17)
Grabe, HJ (17)
Degenhardt, F (17)
Fasching, PA (17)
Beckmann, MW (17)
Lambrechts, D (17)
Easton, DF (17)
Treutlein, J (17)
Witt, SH (17)
visa färre...
Lärosäte
Karolinska Institutet (129)
Uppsala universitet (28)
Lunds universitet (25)
Umeå universitet (16)
Göteborgs universitet (14)
Stockholms universitet (6)
visa fler...
Örebro universitet (6)
Linköpings universitet (4)
Chalmers tekniska högskola (4)
Kungliga Tekniska Högskolan (3)
Högskolan Dalarna (2)
Handelshögskolan i Stockholm (1)
Linnéuniversitetet (1)
Karlstads universitet (1)
Marie Cederschiöld högskola (1)
Sveriges Lantbruksuniversitet (1)
visa färre...
Språk
Engelska (151)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (64)
Naturvetenskap (13)
Samhällsvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy